Longshot, the recent acquisition adds $2.5m to ebitda. Second half ebit was $3.2m off slightly lower revenue for the half of $25m. The new MD/CEO stated in the update there would be lower revenue , but higher ebit plus he eluded to the acquisition in that update.
Guidance will be the key, because we pretty much know what happened in 16/17.
As a minimum you would think ebit guidance would be around $9m, although I am not sure exactly when the acquisition's revenues kick in. Irrespective, with a likely $9m ebit base, and a seemingly decent plan to get back on the growth path, the current $36m market cap seems extremely cheap.
I now hold just over 6.5m shares, and very happy to do so. I am looking forward to attending the AGM this year, especially if we are back above 20c, which would seem highly likely!!
- Forums
- ASX - By Stock
- IMS
- Why
Why, page-69
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)